25 XP   0   0   10

Yantai Dongcheng Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Yantai Dongcheng Pharmaceutical Co Ltd together

PenkeI guess you are interested in Yantai Dongcheng Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Yantai Dongcheng Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Yantai Dongcheng Pharmaceutical Co Ltd

I send you an email if I find something interesting about Yantai Dongcheng Pharmaceutical Co Ltd.

Quick analysis of Yantai Dongcheng Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Yantai Dongcheng Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.82
Expected worth in 1 year
¥6.73
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
¥0.22
Return On Investment
1.6%

For what price can you sell your share?

Current Price per Share
¥13.66
Expected price per share
¥10.76 - ¥16.46
How sure are you?
50%

1. Valuation of Yantai Dongcheng Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥13.66

Intrinsic Value Per Share

¥-14.06 - ¥-17.10

Total Value Per Share

¥-7.23 - ¥-10.27

2. Growth of Yantai Dongcheng Pharmaceutical Co Ltd (5 min.)




Is Yantai Dongcheng Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$778.8m$724m$26.3m3.5%

How much money is Yantai Dongcheng Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$9m$7.6m$1.4m16.3%
Net Profit Margin7.5%6.4%--

How much money comes from the company's main activities?

3. Financial Health of Yantai Dongcheng Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Yantai Dongcheng Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Yantai Dongcheng Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Yantai Dongcheng Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Yantai Dongcheng Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Yantai Dongcheng Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Yantai Dongcheng Pharmaceutical Co Ltd is ¥13.66. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yantai Dongcheng Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yantai Dongcheng Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.82. Based on the TTM, the Book Value Change Per Share is ¥-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yantai Dongcheng Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share0.030.2%0.000.0%0.020.2%0.010.1%0.020.1%
Usd Dividend Per Share0.030.2%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.060.5%0.010.1%0.030.2%0.020.2%0.030.2%
Usd Price Per Share2.30-2.22-1.93-2.16-2.70-
Price to Earnings Ratio33.77--6.22-15.18-20.37-102.63-
Price-to-Total Gains Ratio37.05-75.11-14.75-44.46--1,874.32-
Price to Book Ratio2.44-2.44-2.21-2.53-6.71-
Price-to-Total Gains Ratio37.05-75.11-14.75-44.46--1,874.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.890544
Number of shares528
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.02
Gains per Quarter (528 shares)3.9810.91
Gains per Year (528 shares)15.9343.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
123-76251934
246-1422493878
369-21387457122
492-28549976166
5115-357012494210
6138-4386148113254
7161-50102173132298
8184-57118198151342
9207-64134223170386
10230-71150247189430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%37.03.00.092.5%44.03.00.093.6%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%14.06.00.070.0%33.07.00.082.5%40.07.00.085.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%47.00.00.0100.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%35.05.00.087.5%42.05.00.089.4%

Fundamentals of Yantai Dongcheng Pharmaceutical Co Ltd

About Yantai Dongcheng Pharmaceutical Co Ltd

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule. In addition, it offers Technetium [99Tc] Methylene Diphosphonate Injection; Technetium [99mTc] Tc labeled tracers; 2-[18F]FDG that helps to detect the activity of tumor cells; sodium iodide [131I] oral solution; iodine [125I] seed use to treat internal radiation of various malignant tumors; [14C]Urea capsule; and jiabaolin glucosamine chondroitin sulfate capsule. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.

Fundamental data was last updated by Penke on 2024-03-24 04:28:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Yantai Dongcheng Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Yantai Dongcheng Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.7% means that ¥0.13 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 12.7%. The company is making a huge profit. +2
  • The TTM is 7.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ12.7%TTM7.5%+5.1%
TTM7.5%YOY6.4%+1.1%
TTM7.5%5Y8.4%-0.8%
5Y8.4%10Y10.1%-1.7%
1.1.2. Return on Assets

Shows how efficient Yantai Dongcheng Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.2% Return on Assets means that Yantai Dongcheng Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM0.8%+0.4%
TTM0.8%YOY0.7%+0.1%
TTM0.8%5Y0.9%-0.1%
5Y0.9%10Y1.1%-0.2%
1.1.3. Return on Equity

Shows how efficient Yantai Dongcheng Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.0% Return on Equity means Yantai Dongcheng Pharmaceutical Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM1.3%+0.7%
TTM1.3%YOY1.1%+0.2%
TTM1.3%5Y1.5%-0.2%
5Y1.5%10Y1.6%-0.1%

1.2. Operating Efficiency of Yantai Dongcheng Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Yantai Dongcheng Pharmaceutical Co Ltd is operating .

  • Measures how much profit Yantai Dongcheng Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 16.7% means the company generated ¥0.17  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 16.7%. The company is operating efficient. +1
  • The TTM is 15.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ16.7%TTM15.1%+1.5%
TTM15.1%YOY17.0%-1.8%
TTM15.1%5Y16.5%-1.4%
5Y16.5%10Y9.5%+7.0%
1.2.2. Operating Ratio

Measures how efficient Yantai Dongcheng Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.41 means that the operating costs are ¥1.41 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 1.410. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.407. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.410TTM1.407+0.004
TTM1.407YOY1.426-0.019
TTM1.4075Y1.341+0.066
5Y1.34110Y0.976+0.365

1.3. Liquidity of Yantai Dongcheng Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Yantai Dongcheng Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.35 means the company has ¥1.35 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 1.349. The company is just able to pay all its short-term debts.
  • The TTM is 1.315. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.349TTM1.315+0.034
TTM1.315YOY1.359-0.043
TTM1.3155Y1.417-0.102
5Y1.41710Y0.786+0.631
1.3.2. Quick Ratio

Measures if Yantai Dongcheng Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.39 means the company can pay off ¥0.39 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 0.394. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.397. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.394TTM0.397-0.003
TTM0.397YOY0.467-0.069
TTM0.3975Y0.553-0.156
5Y0.55310Y0.726-0.173

1.4. Solvency of Yantai Dongcheng Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Yantai Dongcheng Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Yantai Dongcheng Pharmaceutical Co Ltd assets are financed with 32.1% credit (debt) and the remaining percentage (100% - 32.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 0.321. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.345. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.321TTM0.345-0.024
TTM0.345YOY0.344+0.001
TTM0.3455Y0.334+0.011
5Y0.33410Y0.277+0.058
1.4.2. Debt to Equity Ratio

Measures if Yantai Dongcheng Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 53.1% means that company has ¥0.53 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The MRQ is 0.531. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.589. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.589-0.059
TTM0.589YOY0.601-0.012
TTM0.5895Y0.566+0.023
5Y0.56610Y0.448+0.118

2. Market Valuation of Yantai Dongcheng Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Yantai Dongcheng Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Yantai Dongcheng Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 33.77 means the investor is paying ¥33.77 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The EOD is 27.742. Based on the earnings, the company is overpriced. -1
  • The MRQ is 33.774. Based on the earnings, the company is overpriced. -1
  • The TTM is -6.215. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD27.742MRQ33.774-6.032
MRQ33.774TTM-6.215+39.989
TTM-6.215YOY15.182-21.398
TTM-6.2155Y20.370-26.585
5Y20.37010Y102.631-82.261
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The EOD is -82.235. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -100.115. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -42.289. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-82.235MRQ-100.115+17.880
MRQ-100.115TTM-42.289-57.826
TTM-42.289YOY-3.665-38.624
TTM-42.2895Y107.639-149.928
5Y107.63910Y92.470+15.169
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Yantai Dongcheng Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Yantai Dongcheng Pharmaceutical Co Ltd:

  • The EOD is 2.001. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.437. Based on the equity, the company is underpriced. +1
  • The TTM is 2.442. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.001MRQ2.437-0.435
MRQ2.437TTM2.442-0.006
TTM2.442YOY2.208+0.234
TTM2.4425Y2.531-0.088
5Y2.53110Y6.706-4.176
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Yantai Dongcheng Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.238-0.024+110%0.180+32%0.065+268%0.138+73%
Book Value Per Share--6.8256.575+4%6.345+8%6.157+11%4.518+51%
Current Ratio--1.3491.315+3%1.359-1%1.417-5%0.786+72%
Debt To Asset Ratio--0.3210.345-7%0.344-7%0.334-4%0.277+16%
Debt To Equity Ratio--0.5310.589-10%0.601-12%0.566-6%0.448+18%
Dividend Per Share--0.2110.079+168%0.062+239%0.085+149%0.059+257%
Eps--0.1230.080+55%0.067+84%0.085+45%0.064+92%
Free Cash Flow Per Share---0.0420.011-490%0.126-133%0.095-144%0.075-156%
Free Cash Flow To Equity Per Share--0.015-0.103+800%0.189-92%0.028-48%0.130-89%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---17.098--------
Intrinsic Value_10Y_min---14.058--------
Intrinsic Value_1Y_max--0.062--------
Intrinsic Value_1Y_min--0.061--------
Intrinsic Value_3Y_max---1.168--------
Intrinsic Value_3Y_min---1.088--------
Intrinsic Value_5Y_max---4.028--------
Intrinsic Value_5Y_min---3.622--------
Market Cap11263980922.880-22%13713030947.84013234765286.400+4%11509298223.360+19%12841845307.648+7%16059422897.764-15%
Net Profit Margin--0.1270.075+68%0.064+97%0.084+51%0.101+26%
Operating Margin--0.1670.151+10%0.170-2%0.165+1%0.095+74%
Operating Ratio--1.4101.407+0%1.426-1%1.341+5%0.976+44%
Pb Ratio2.001-22%2.4372.4420%2.208+10%2.531-4%6.706-64%
Pe Ratio27.742-22%33.774-6.215+118%15.182+122%20.370+66%102.631-67%
Price Per Share13.660-22%16.63016.050+4%13.958+19%15.574+7%19.476-15%
Price To Free Cash Flow Ratio-82.235+18%-100.115-42.289-58%-3.665-96%107.639-193%92.470-208%
Price To Total Gains Ratio30.432-22%37.04875.105-51%14.751+151%44.459-17%-1874.317+5159%
Quick Ratio--0.3940.397-1%0.467-15%0.553-29%0.726-46%
Return On Assets--0.0120.008+55%0.007+88%0.009+33%0.011+12%
Return On Equity--0.0200.013+51%0.011+78%0.015+31%0.016+24%
Total Gains Per Share--0.4490.055+724%0.243+85%0.149+201%0.197+128%
Usd Book Value--778887946.435750395593.220+4%724094070.775+8%702633160.094+11%515610939.365+51%
Usd Book Value Change Per Share--0.033-0.003+110%0.025+32%0.009+268%0.019+73%
Usd Book Value Per Share--0.9450.910+4%0.878+8%0.852+11%0.625+51%
Usd Dividend Per Share--0.0290.011+168%0.009+239%0.012+149%0.008+257%
Usd Eps--0.0170.011+55%0.009+84%0.012+45%0.009+92%
Usd Free Cash Flow---4739246.6871214867.338-490%14349658.255-133%10859610.109-144%6802957.598-170%
Usd Free Cash Flow Per Share---0.0060.001-490%0.017-133%0.013-144%0.010-156%
Usd Free Cash Flow To Equity Per Share--0.002-0.014+800%0.026-92%0.004-48%0.018-89%
Usd Market Cap1558934959.727-22%1897883483.1811831691515.638+4%1592886874.113+19%1777311390.578+7%2222624129.051-15%
Usd Price Per Share1.891-22%2.3022.221+4%1.932+19%2.155+7%2.695-15%
Usd Profit--14048309.6409092558.189+55%7614398.616+84%9714757.296+45%7318979.652+92%
Usd Revenue--110766106.101118569277.696-7%133488112.087-17%118984724.871-7%80720021.662+37%
Usd Total Gains Per Share--0.0620.008+724%0.034+85%0.021+201%0.027+128%
 EOD+3 -5MRQTTM+26 -9YOY+23 -125Y+23 -1210Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of Yantai Dongcheng Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.742
Price to Book Ratio (EOD)Between0-12.001
Net Profit Margin (MRQ)Greater than00.127
Operating Margin (MRQ)Greater than00.167
Quick Ratio (MRQ)Greater than10.394
Current Ratio (MRQ)Greater than11.349
Debt to Asset Ratio (MRQ)Less than10.321
Debt to Equity Ratio (MRQ)Less than10.531
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.012
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Yantai Dongcheng Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.188
Ma 20Greater thanMa 5015.015
Ma 50Greater thanMa 10015.178
Ma 100Greater thanMa 20016.601
OpenGreater thanClose14.030
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,288,822
Total Liabilities2,661,019
Total Stockholder Equity5,015,691
 As reported
Total Liabilities 2,661,019
Total Stockholder Equity+ 5,015,691
Total Assets = 8,288,822

Assets

Total Assets8,288,822
Total Current Assets2,856,240
Long-term Assets5,432,582
Total Current Assets
Cash And Cash Equivalents 792,596
Net Receivables 835,088
Inventory 1,096,044
Other Current Assets 132,511
Total Current Assets  (as reported)2,856,240
Total Current Assets  (calculated)2,856,240
+/- 0
Long-term Assets
Property Plant Equipment 2,108,427
Goodwill 2,547,028
Intangible Assets 400,553
Other Assets 388,359
Long-term Assets  (as reported)5,432,582
Long-term Assets  (calculated)5,444,368
+/- 11,785

Liabilities & Shareholders' Equity

Total Current Liabilities2,117,052
Long-term Liabilities543,967
Total Stockholder Equity5,015,691
Total Current Liabilities
Short Long Term Debt 420,788
Accounts payable 1,004,877
Other Current Liabilities 480,179
Total Current Liabilities  (as reported)2,117,052
Total Current Liabilities  (calculated)1,905,845
+/- 211,208
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,892
Other Liabilities 255,201
Deferred Long Term Liability 219,538
Long-term Liabilities  (as reported)543,967
Long-term Liabilities  (calculated)481,632
+/- 62,335
Total Stockholder Equity
Common Stock824,596
Retained Earnings 1,679,321
Other Stockholders Equity 4,107
Total Stockholder Equity (as reported)5,015,691
Total Stockholder Equity (calculated)2,508,024
+/- 2,507,667
Other
Capital Stock824,596
Common Stock Shares Outstanding 824,596
Net Invested Capital 5,718,353
Net Tangible Assets 2,251,103
Net Working Capital 739,187
Property Plant and Equipment Gross 2,108,427



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312010-12-312009-12-31
> Total Assets 
266,963
359,195
451,238
400,311
1,065,449
1,026,046
1,088,359
1,093,005
1,262,506
1,216,655
1,228,499
1,245,660
1,323,075
1,330,771
1,393,354
1,425,133
1,467,990
2,489,472
2,547,915
2,743,989
2,882,261
2,979,122
4,267,939
4,223,278
4,349,219
4,958,120
5,273,152
5,357,413
6,433,312
6,826,832
6,967,350
6,854,153
7,168,809
7,445,096
7,294,961
7,081,331
7,246,860
7,513,984
7,393,206
7,558,464
7,512,930
7,569,608
7,656,281
7,815,615
7,900,907
8,502,556
8,176,965
8,264,585
8,380,958
8,288,822
8,288,8228,380,9588,264,5858,176,9658,502,5567,900,9077,815,6157,656,2817,569,6087,512,9307,558,4647,393,2067,513,9847,246,8607,081,3317,294,9617,445,0967,168,8096,854,1536,967,3506,826,8326,433,3125,357,4135,273,1524,958,1204,349,2194,223,2784,267,9392,979,1222,882,2612,743,9892,547,9152,489,4721,467,9901,425,1331,393,3541,330,7711,323,0751,245,6601,228,4991,216,6551,262,5061,093,0051,088,3591,026,0461,065,449400,311451,238359,195266,963
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,416,904
2,762,715
2,868,519
2,739,937
2,848,095
3,048,327
3,078,222
2,834,546
2,927,050
3,031,591
2,945,108
3,018,176
2,775,908
2,790,731
2,899,769
2,917,954
2,925,867
3,501,111
3,192,720
3,230,854
3,202,585
2,856,240
2,856,2403,202,5853,230,8543,192,7203,501,1112,925,8672,917,9542,899,7692,790,7312,775,9083,018,1762,945,1083,031,5912,927,0502,834,5463,078,2223,048,3272,848,0952,739,9372,868,5192,762,7152,416,9040000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
467,999
897,168
911,491
790,493
598,682
561,990
824,764
601,181
507,501
525,551
715,790
747,979
498,845
615,225
826,611
726,478
810,450
1,268,549
1,021,624
868,287
925,927
792,596
792,596925,927868,2871,021,6241,268,549810,450726,478826,611615,225498,845747,979715,790525,551507,501601,181824,764561,990598,682790,493911,491897,168467,9990000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
429,500
0
319,500
0
380,500
400,500
222,111
290,000
214,351
349,690
118,036
120,000
239,698
193,380
129,273
149,420
108,444
36,200
27,327
68,840
25,290
0
025,29068,84027,32736,200108,444149,420129,273193,380239,698120,000118,036349,690214,351290,000222,111400,500380,5000319,5000429,5000000000000000000000000000000
       Net Receivables 
54,080
67,148
77,307
101,263
116,708
110,151
118,608
151,914
157,994
165,577
180,711
161,098
198,581
203,289
194,810
196,971
239,999
357,731
382,928
366,100
381,391
401,559
545,750
580,858
605,595
616,855
671,485
633,567
796,641
870,649
984,272
872,565
913,728
1,006,007
1,030,647
1,037,490
1,183,315
1,068,010
1,018,338
1,103,057
1,011,749
936,761
889,396
956,309
922,686
995,456
945,662
948,773
922,755
835,088
835,088922,755948,773945,662995,456922,686956,309889,396936,7611,011,7491,103,0571,018,3381,068,0101,183,3151,037,4901,030,6471,006,007913,728872,565984,272870,649796,641633,567671,485616,855605,595580,858545,750401,559381,391366,100382,928357,731239,999196,971194,810203,289198,581161,098180,711165,577157,994151,914118,608110,151116,708101,26377,30767,14854,080
       Other Current Assets 
11,252
8,873
5,176
15,632
12,974
11,621
9,510
16,025
18,317
28,623
90,974
19,983
9,961
10,579
10,721
8,032
17,797
22,976
13,141
15,452
16,048
31,888
33,564
305,679
75,449
460,667
31,319
354,393
88,735
413,652
49,380
292,120
42,621
57,342
112,844
83,728
142,814
112,458
118,916
115,180
90,979
105,799
101,960
114,167
119,080
134,691
120,054
148,063
144,679
132,511
132,511144,679148,063120,054134,691119,080114,167101,960105,79990,979115,180118,916112,458142,81483,728112,84457,34242,621292,12049,380413,65288,735354,39331,319460,66775,449305,67933,56431,88816,04815,45213,14122,97617,7978,03210,72110,5799,96119,98390,97428,62318,31716,0259,51011,62112,97415,6325,1768,87311,252
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,114,216
4,320,714
4,396,770
4,216,739
4,246,784
4,319,810
4,482,393
4,448,099
4,540,288
4,737,023
4,778,877
4,756,513
4,897,660
4,975,040
5,001,445
4,984,245
5,033,731
5,178,373
5,432,582
5,432,5825,178,3735,033,7314,984,2455,001,4454,975,0404,897,6604,756,5134,778,8774,737,0234,540,2884,448,0994,482,3934,319,8104,246,7844,216,7394,396,7704,320,7144,114,2160000000000000000000000000000000
       Property Plant Equipment 
70,014
77,733
97,588
86,909
95,168
100,004
158,227
129,436
207,355
265,847
381,443
323,844
329,651
336,243
376,240
366,857
373,024
407,846
431,976
436,677
454,708
489,960
587,724
622,528
628,164
639,567
638,420
671,188
917,049
928,790
952,385
972,953
1,082,611
1,119,690
1,115,919
1,127,949
1,147,830
1,256,008
1,285,898
1,368,577
1,439,905
1,478,652
1,616,073
1,752,237
1,785,376
1,885,590
1,963,803
2,019,950
2,073,805
2,108,427
2,108,4272,073,8052,019,9501,963,8031,885,5901,785,3761,752,2371,616,0731,478,6521,439,9051,368,5771,285,8981,256,0081,147,8301,127,9491,115,9191,119,6901,082,611972,953952,385928,790917,049671,188638,420639,567628,164622,528587,724489,960454,708436,677431,976407,846373,024366,857376,240336,243329,651323,844381,443265,847207,355129,436158,227100,00495,16886,90997,58877,73370,014
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
124,667
124,667
124,667
124,667
124,667
124,667
708,474
708,474
708,474
708,474
708,474
1,472,928
1,468,416
1,453,548
1,438,014
1,428,995
1,400,628
2,672,349
2,722,696
2,697,557
2,684,299
2,731,869
2,752,464
2,567,355
2,578,487
2,577,915
2,632,531
2,599,982
2,604,725
2,593,358
2,595,944
2,373,473
2,370,662
2,394,153
2,418,079
2,329,646
2,323,928
2,345,737
2,547,028
2,547,0282,345,7372,323,9282,329,6462,418,0792,394,1532,370,6622,373,4732,595,9442,593,3582,604,7252,599,9822,632,5312,577,9152,578,4872,567,3552,752,4642,731,8692,684,2992,697,5572,722,6962,672,3491,400,6281,428,9951,438,0141,453,5481,468,4161,472,928708,474708,474708,474708,474708,474124,667124,667124,667124,667124,667124,66700000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,472
88,373
81,893
99,547
115,523
119,260
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000119,260115,52399,54781,89388,37388,4720000000000000000000000000000
       Intangible Assets 
9,757
10,304
70
9,946
37
9,920
121
39,142
65,958
190,353
155
188,251
187,970
187,038
193,490
192,542
191,636
805,969
804,579
802,743
801,098
799,748
1,594,295
1,588,578
1,570,853
1,555,002
1,578,651
1,522,082
167,563
165,786
166,743
235,292
123,652
269,853
255,217
258,872
268,946
262,801
279,425
278,378
278,285
281,199
308,971
311,561
326,502
328,993
321,968
321,770
395,619
400,553
400,553395,619321,770321,968328,993326,502311,561308,971281,199278,285278,378279,425262,801268,946258,872255,217269,853123,652235,292166,743165,786167,5631,522,0821,578,6511,555,0021,570,8531,588,5781,594,295799,748801,098802,743804,579805,969191,636192,542193,490187,038187,970188,251155190,35365,95839,1421219,920379,9467010,3049,757
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,645
28,779
28,657
63,465
68,145
108,216
1,351,302
41,663
50,738
57,475
73,223
95,247
90,318
107,548
68,212
72,238
77,115
80,806
104,278
104,27880,80677,11572,23868,212107,54890,31895,24773,22357,47550,73841,6631,351,302108,21668,14563,46528,65728,77926,6450000000000000000000000000000000
> Total Liabilities 
126,531
168,136
146,819
94,093
89,906
26,907
72,845
42,855
205,105
137,533
127,177
118,964
186,969
172,629
209,064
242,286
259,686
289,938
311,943
505,599
591,287
629,813
1,183,947
1,099,815
1,171,347
1,691,782
1,984,381
2,017,589
2,203,006
2,265,364
2,356,734
2,225,324
2,301,057
2,396,504
2,516,045
2,180,898
2,379,366
2,409,353
2,427,549
2,497,803
2,537,761
2,457,083
2,632,511
2,730,240
2,790,315
2,794,718
2,894,620
2,918,620
2,949,338
2,661,019
2,661,0192,949,3382,918,6202,894,6202,794,7182,790,3152,730,2402,632,5112,457,0832,537,7612,497,8032,427,5492,409,3532,379,3662,180,8982,516,0452,396,5042,301,0572,225,3242,356,7342,265,3642,203,0062,017,5891,984,3811,691,7821,171,3471,099,8151,183,947629,813591,287505,599311,943289,938259,686242,286209,064172,629186,969118,964127,177137,533205,10542,85572,84526,90789,90694,093146,819168,136126,531
   > Total Current Liabilities 
96,531
168,136
146,819
94,093
89,906
26,907
61,245
31,255
193,505
125,933
115,868
107,654
176,240
162,190
197,622
221,125
238,702
265,294
277,921
463,909
549,945
588,830
1,119,684
788,171
893,348
970,311
1,280,592
1,430,484
1,598,885
1,728,769
1,993,391
1,998,527
2,073,068
2,166,174
2,431,609
1,820,109
1,946,457
1,791,946
1,897,003
1,960,889
1,926,219
1,853,195
2,042,949
2,144,961
2,403,617
2,435,366
2,393,379
2,447,540
2,546,447
2,117,052
2,117,0522,546,4472,447,5402,393,3792,435,3662,403,6172,144,9612,042,9491,853,1951,926,2191,960,8891,897,0031,791,9461,946,4571,820,1092,431,6092,166,1742,073,0681,998,5271,993,3911,728,7691,598,8851,430,4841,280,592970,311893,348788,1711,119,684588,830549,945463,909277,921265,294238,702221,125197,622162,190176,240107,654115,868125,933193,50531,25561,24526,90789,90694,093146,819168,13696,531
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
254,431
255,234
392,415
491,801
562,164
603,444
556,931
644,644
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000644,644556,931603,444562,164491,801392,415255,234254,4310000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
254,431
255,234
392,415
491,801
562,164
603,444
556,931
644,644
779,841
508,417
457,062
457,563
377,942
355,706
306,400
288,672
358,062
403,751
343,819
459,701
485,623
420,788
420,788485,623459,701343,819403,751358,062288,672306,400355,706377,942457,563457,062508,417779,841644,644556,931603,444562,164491,801392,415255,234254,4310000000000000000000000000000
       Accounts payable 
23,044
54,662
59,471
29,337
47,148
13,924
37,102
30,352
68,767
54,831
27,095
32,152
35,899
24,901
51,711
33,211
44,540
32,530
52,021
48,325
58,852
71,237
76,101
76,523
119,651
130,028
201,960
211,731
189,019
254,027
236,680
230,478
379,170
535,752
582,432
569,589
595,602
720,605
719,082
814,202
942,079
911,580
1,052,226
1,175,886
1,202,888
1,301,694
1,331,808
1,284,004
1,203,932
1,004,877
1,004,8771,203,9321,284,0041,331,8081,301,6941,202,8881,175,8861,052,226911,580942,079814,202719,082720,605595,602569,589582,432535,752379,170230,478236,680254,027189,019211,731201,960130,028119,65176,52376,10171,23758,85248,32552,02132,53044,54033,21151,71124,90135,89932,15227,09554,83168,76730,35237,10213,92447,14829,33759,47154,66223,044
       Other Current Liabilities 
2,125
0
1,425
14,759
12,641
11,183
22,343
903
48,056
4,051
41,245
40,682
50,275
12,461
48,006
60,199
33,499
51,742
79,546
101,982
93,247
98,316
350,073
271,612
222,302
288,325
512,923
515,523
537,694
736,419
599,963
423,406
240,488
146,648
596,395
540,686
186,652
500,994
256,715
533,558
172,295
365,321
436,536
432,608
233,036
438,222
568,220
551,894
482,524
480,179
480,179482,524551,894568,220438,222233,036432,608436,536365,321172,295533,558256,715500,994186,652540,686596,395146,648240,488423,406599,963736,419537,694515,523512,923288,325222,302271,612350,07398,31693,247101,98279,54651,74233,49960,19948,00612,46150,27540,68241,2454,05148,05690322,34311,18312,64114,7591,42502,125
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
226,797
227,989
230,331
84,436
360,789
432,910
617,406
530,546
536,914
611,542
603,888
589,562
585,279
386,698
359,353
501,241
471,080
402,891
543,967
543,967402,891471,080501,241359,353386,698585,279589,562603,888611,542536,914530,546617,406432,910360,78984,436230,331227,989226,7970000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
11,600
11,600
11,600
11,600
11,309
11,309
10,729
10,439
10,601
20,311
20,021
23,475
32,698
3,588
39,945
38,201
52,523
51,789
49,686
49,881
67,408
67,244
88,451
90,511
83,998
81,052
81,559
81,785
78,276
77,543
77,227
74,857
82,013
79,467
77,432
75,048
66,309
64,271
62,482
60,637
261,108
259,038
256,956
255,201
255,201256,956259,038261,10860,63762,48264,27166,30975,04877,43279,46782,01374,85777,22777,54378,27681,78581,55981,05283,99890,51188,45167,24467,40849,88149,68651,78952,52338,20139,9453,58832,69823,47520,02120,31110,60110,43910,72911,30911,30911,60011,60011,60011,600000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,588
80,258
110,727
113,111
123,006
125,543
116,827
118,871
125,242
147,421
142,817
141,806
152,975
149,093
177,029
186,920
185,765
167,331
133,241
138,339
205,329
219,538
219,538205,329138,339133,241167,331185,765186,920177,029149,093152,975141,806142,817147,421125,242118,871116,827125,543123,006113,111110,72780,258100,5880000000000000000000000000000
> Total Stockholder Equity
140,227
190,867
304,221
306,046
975,385
999,023
1,015,438
1,050,113
1,046,730
1,067,439
1,087,769
1,112,260
1,120,309
1,141,492
1,168,958
1,166,895
1,192,882
2,026,852
2,047,985
2,040,452
2,079,227
2,121,504
2,767,760
2,776,689
2,813,305
2,874,405
2,902,576
2,932,429
3,800,660
4,131,835
4,183,710
4,200,246
4,330,020
4,447,641
4,292,713
4,365,458
4,317,180
4,409,266
4,468,323
4,533,424
4,407,451
4,509,596
4,397,415
4,437,626
4,440,161
4,978,432
4,748,680
4,792,969
4,846,882
5,015,691
5,015,6914,846,8824,792,9694,748,6804,978,4324,440,1614,437,6264,397,4154,509,5964,407,4514,533,4244,468,3234,409,2664,317,1804,365,4584,292,7134,447,6414,330,0204,200,2464,183,7104,131,8353,800,6602,932,4292,902,5762,874,4052,813,3052,776,6892,767,7602,121,5042,079,2272,040,4522,047,9852,026,8521,192,8821,166,8951,168,9581,141,4921,120,3091,112,2601,087,7691,067,4391,046,7301,050,1131,015,438999,023975,385306,046304,221190,867140,227
   Common Stock
48,000
54,000
81,000
81,000
108,000
108,000
108,000
108,000
108,000
172,800
172,800
172,800
172,800
172,800
172,800
172,800
172,800
220,607
220,607
220,607
220,607
661,820
703,603
703,603
703,603
703,603
703,603
703,603
775,499
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
802,214
824,596
824,596
824,596
824,596
824,596
824,596824,596824,596824,596824,596802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214802,214775,499703,603703,603703,603703,603703,603703,603661,820220,607220,607220,607220,607172,800172,800172,800172,800172,800172,800172,800172,800108,000108,000108,000108,000108,00081,00081,00054,00048,000
   Retained Earnings 
34,296
77,492
171,591
173,416
203,386
227,025
227,172
261,854
259,811
269,769
277,376
365,682
373,730
394,913
422,442
420,335
446,376
465,108
486,267
478,758
517,243
559,451
592,953
596,049
637,664
703,068
737,442
780,843
830,406
912,148
998,872
889,502
1,003,151
1,103,866
1,115,080
1,188,950
1,133,766
1,252,732
1,332,292
1,399,191
1,286,698
1,393,541
1,290,100
1,345,022
1,338,508
1,500,078
1,517,199
1,567,306
1,577,816
1,679,321
1,679,3211,577,8161,567,3061,517,1991,500,0781,338,5081,345,0221,290,1001,393,5411,286,6981,399,1911,332,2921,252,7321,133,7661,188,9501,115,0801,103,8661,003,151889,502998,872912,148830,406780,843737,442703,068637,664596,049592,953559,451517,243478,758486,267465,108446,376420,335422,442394,913373,730365,682277,376269,769259,811261,854227,172227,025203,386173,416171,59177,49234,296
   Capital Surplus 00000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,617
37,873
34,862
25,384
41,509
58,415
52,990
51,865
58,771
31,890
13,107
11,598
-1,612
-6,051
-11,784
-13,983
-9,558
41,855
4,845
2,381
2,334
4,107
4,1072,3342,3814,84541,855-9,558-13,983-11,784-6,051-1,61211,59813,10731,89058,77151,86552,99058,41541,50925,38434,86237,87312,6170000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,426,858
Cost of Revenue-1,910,731
Gross Profit1,516,1271,516,127
 
Operating Income (+$)
Gross Profit1,516,127
Operating Expense-2,909,830
Operating Income517,028-1,393,703
 
Operating Expense (+$)
Research Development189,019
Selling General Administrative644,741
Selling And Marketing Expenses-
Operating Expense2,909,830833,760
 
Net Interest Income (+$)
Interest Income11,295
Interest Expense-45,046
Other Finance Cost-41,944
Net Interest Income-75,695
 
Pretax Income (+$)
Operating Income517,028
Net Interest Income-75,695
Other Non-Operating Income Expenses-
Income Before Tax (EBT)394,091517,028
EBIT - interestExpense = -45,046
262,791
307,837
Interest Expense45,046
Earnings Before Interest and Taxes (EBIT)-439,137
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax394,091
Tax Provision-83,368
Net Income From Continuing Ops310,723310,723
Net Income262,791
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-75,695
 

Technical Analysis of Yantai Dongcheng Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yantai Dongcheng Pharmaceutical Co Ltd. The general trend of Yantai Dongcheng Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yantai Dongcheng Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Yantai Dongcheng Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 14.05 < 16.22 < 16.46.

The bearish price targets are: 12.05 > 11.81 > 10.76.

Tweet this
Yantai Dongcheng Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Yantai Dongcheng Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Yantai Dongcheng Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Yantai Dongcheng Pharmaceutical Co Ltd. The current macd is -0.23041728.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Yantai Dongcheng Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Yantai Dongcheng Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Yantai Dongcheng Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Yantai Dongcheng Pharmaceutical Co Ltd. The current adx is 18.74.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Yantai Dongcheng Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Yantai Dongcheng Pharmaceutical Co Ltd. The current sar is 16.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Yantai Dongcheng Pharmaceutical Co Ltd. The current rsi is 34.19. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Yantai Dongcheng Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Yantai Dongcheng Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Yantai Dongcheng Pharmaceutical Co Ltd. The current cci is -158.53634085.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Yantai Dongcheng Pharmaceutical Co Ltd. The current cmo is -46.12290228.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Yantai Dongcheng Pharmaceutical Co Ltd. The current willr is -93.64548495.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Williams %R ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Yantai Dongcheng Pharmaceutical Co Ltd.

Yantai Dongcheng Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Yantai Dongcheng Pharmaceutical Co Ltd. The current atr is 0.5757425.

Yantai Dongcheng Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Yantai Dongcheng Pharmaceutical Co Ltd. The current obv is 183,427,012.

Yantai Dongcheng Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Yantai Dongcheng Pharmaceutical Co Ltd. The current mfi is 44.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Yantai Dongcheng Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartYantai Dongcheng Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Yantai Dongcheng Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Yantai Dongcheng Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Yantai Dongcheng Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.188
Ma 20Greater thanMa 5015.015
Ma 50Greater thanMa 10015.178
Ma 100Greater thanMa 20016.601
OpenGreater thanClose14.030
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Yantai Dongcheng Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Yantai Dongcheng Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yantai Dongcheng Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Yantai Dongcheng Pharmaceutical Co Ltd

I send you an email if I find something interesting about Yantai Dongcheng Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Yantai Dongcheng Pharmaceutical Co Ltd.

Receive notifications about Yantai Dongcheng Pharmaceutical Co Ltd in your mailbox!